Filing Flows › DexCom (DXCM) › Q2 2026
DexCom (DXCM) Q2 2026 earnings results (second quarter 2026)
10-Q filed Jul 30, 2026
DexCom (DXCM) reported revenue of $1.3B for the second quarter 2026 (Q2 2026), +13% from a year earlier and +10% from the quarter before. Operating margin was 24.3%, net earnings $249M (19.0% of revenue).
DexCom, Q2 2026: revenue $1.3B (+13% year over year), operating margin 24.3%, net earnings $249M, operating cash flow $269M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.3B | +10% | +13% |
| Gross profit | $830M | +11% | +20% |
| Operating profit | $318M | +25% | +50% |
| Net earnings | $249M | +25% | +39% |
| Operating cash flow | $269M | -49% | -11% |
| Free cash flow | $184M | -59% | -12% |
What changed
Revenue was $1.3B in Q2 2026, up 13% year over year and up 10% from the previous quarter.
Gross margin was 63.4%, up 3.9 points from Q2 2025. Operating profit was $0.32B, a 24.3% margin (up 6.0 points year over year). Of the extra revenue versus Q2 2025, 70% reached operating profit, above the 18% margin then. Operating expenses grew 7% against revenue growth of 13%. Net earnings were $0.25B, up 39% year over year. The effective tax rate was 21.5%.
Operating cash flow was $0.27B (down 11% year over year), 108% of net earnings. Non-cash charges added back $0.07B of depreciation and amortization and $0.04B of share-based compensation. Working capital and other items used $0.09B. Capital expenditures of $0.08B left free cash flow of $0.18B.
Questions
What was DexCom's revenue in the second quarter 2026?
DexCom (DXCM) reported revenue of $1.3B for the second quarter 2026 (Q2 2026), +13% from a year earlier and +10% from the quarter before.
Was DexCom profitable in the second quarter 2026?
Operating profit was $318M (24.3% of revenue) and net earnings $249M.
Source: DexCom 10-Q on SEC EDGAR.